Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innohep versus subcutaneous unfractionated heparin in elderly patients with impaired renal function and acute deep vein thrombosis
2005-002270-29Phase 4Terminated
- Sponsor
- LEO Pharma
- Start
- Nov 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in deep vein thrombosis (DVT) and venous thromboembolism (VTE) comparing Innohep arm with Unfractionated heparin arm (2 arms). Primary endpoint: Clinically relevant bleedings. Started Nov 2005; status: terminated.
02
Drugs
tinzaparinheparin
03
Conditions
deep vein thrombosis (DVT)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2005-002270-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002270-29.